"Hyperkalemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally high potassium concentration in the blood, most often due to defective renal excretion. It is characterized clinically by electrocardiographic abnormalities (elevated T waves and depressed P waves, and eventually by atrial asystole). In severe cases, weakness and flaccid paralysis may occur. (Dorland, 27th ed)
| Descriptor ID |
D006947
|
| MeSH Number(s) |
C18.452.950.396
|
| Concept/Terms |
Hyperkalemia- Hyperkalemia
- Hyperkalemias
- Hyperpotassemia
- Hyperpotassemias
|
Below are MeSH descriptors whose meaning is more general than "Hyperkalemia".
Below are MeSH descriptors whose meaning is more specific than "Hyperkalemia".
This graph shows the total number of publications written about "Hyperkalemia" by people in this website by year, and whether "Hyperkalemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 10 | 4 | 14 |
| 2018 | 18 | 6 | 24 |
| 2019 | 10 | 0 | 10 |
| 2020 | 1 | 1 | 2 |
| 2021 | 1 | 2 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Hyperkalemia" by people in Profiles.
-
Epidemiology, prognosis and management of potassium disorders in Covid-19. Rev Med Virol. 2022 01; 32(1):e2262.
-
Muscle manifestations and CK levels in COVID infection: results of a large cohort of patients inside a Pandemic COVID-19 Area. Acta Myol. 2021 Mar; 40(1):1-7.
-
Safety profile of hydroxychloroquine and azithromycin combined treatment in COVID-19 patients. Int J Antimicrob Agents. 2021 Jan; 57(1):106236.
-
Clinical efficacy and safety profile of hydroxychloroquine and azithromycin against COVID-19. Int J Antimicrob Agents. 2021 Jan; 57(1):106242.
-
Safely reducing haemodialysis frequency during the COVID-19 pandemic. BMC Nephrol. 2020 12 07; 21(1):532.
-
Early Cytokine Removal in Critical COVID-19 Patients with Extracorporeal Therapies (HA-380 plus High Volume Hemofiltration) May Prevent Progression of Acute Respiratory Distress Syndrome: Case Report. Blood Purif. 2021; 50(4-5):575-577.
-
Association between serum potassium levels and short-term mortality in patients with atrial fibrillation or flutter co-treated with diuretics and rate- or rhythm-controlling drugs. Eur Heart J Cardiovasc Pharmacother. 2020 07 01; 6(3):137-144.
-
Covid-19 and acute kidney injury in hospital: summary of NICE guidelines. BMJ. 2020 May 26; 369:m1963.
-
A catabolic state in a kidney transplant recipient with COVID-19. Transpl Int. 2020 09; 33(9):1140-1141.
-
Hyperkalemia and Treatment With RAAS Inhibitors During Acute Heart Failure Hospitalizations and Their Association With Mortality. JACC Heart Fail. 2019 11; 7(11):970-979.